These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
248 related articles for article (PubMed ID: 23913779)
1. Cytomorphologic and molecular features of hobnail variant of papillary thyroid carcinoma: case series and literature review. Asioli S; Maletta F; Pagni F; Pacchioni D; Vanzati A; Mariani S; Palestini N; Lloyd RV; Sapino A Diagn Cytopathol; 2014 Jan; 42(1):78-84. PubMed ID: 23913779 [TBL] [Abstract][Full Text] [Related]
2. Cytologic, clinicopathologic, and molecular features of papillary thyroid carcinoma with prominent hobnail features: 10 case reports and systematic literature review. Lee YS; Kim Y; Jeon S; Bae JS; Jung SL; Jung CK Int J Clin Exp Pathol; 2015; 8(7):7988-97. PubMed ID: 26339365 [TBL] [Abstract][Full Text] [Related]
3. Cytological, molecular, and clinical features of noninvasive follicular thyroid neoplasm with papillary-like nuclear features versus invasive forms of follicular variant of papillary thyroid carcinoma. Zhao L; Dias-Santagata D; Sadow PM; Faquin WC Cancer Cytopathol; 2017 May; 125(5):323-331. PubMed ID: 28192645 [TBL] [Abstract][Full Text] [Related]
4. Value of immunohistochemistry in the detection of BRAF(V600E) mutations in fine-needle aspiration biopsies of papillary thyroid carcinoma. Zimmermann AK; Camenisch U; Rechsteiner MP; Bode-Lesniewska B; Rössle M Cancer Cytopathol; 2014 Jan; 122(1):48-58. PubMed ID: 24039206 [TBL] [Abstract][Full Text] [Related]
5. Papillary thyroid carcinoma with prominent hobnail features: a new aggressive variant of moderately differentiated papillary carcinoma. A clinicopathologic, immunohistochemical, and molecular study of eight cases. Asioli S; Erickson LA; Sebo TJ; Zhang J; Jin L; Thompson GB; Lloyd RV Am J Surg Pathol; 2010 Jan; 34(1):44-52. PubMed ID: 19956062 [TBL] [Abstract][Full Text] [Related]
6. Cytomorphological factors and BRAF mutation predicting risk of lymph node metastasis in preoperative liquid-based fine needle aspirations of papillary thyroid carcinoma. Chung SY; Lee JS; Lee H; Park SH; Kim SJ; Ryu HS Acta Cytol; 2013; 57(3):252-8. PubMed ID: 23636013 [TBL] [Abstract][Full Text] [Related]
7. The Hobnail Variant of Papillary Thyroid Carcinoma: Clinical/Molecular Characteristics of a Large Monocentric Series and Comparison with Conventional Histotypes. Watutantrige-Fernando S; Vianello F; Barollo S; Bertazza L; Galuppini F; Cavedon E; Censi S; Benna C; Ide EC; Parisi A; Nacamulli D; Iacobone M; Pennelli G; Mian C Thyroid; 2018 Jan; 28(1):96-103. PubMed ID: 29179638 [TBL] [Abstract][Full Text] [Related]
8. Mutant-specific BRAF and CD117 immunocytochemistry potentially facilitate risk stratification for papillary thyroid carcinoma in fine-needle aspiration biopsy specimens. Meng Z; Lu J; Wu H; Zhao Y; Luo Y; Gao J; Zhu Q; Jiang Y; Li W; Liang Z Tumour Biol; 2016 Jan; 37(1):611-8. PubMed ID: 26240026 [TBL] [Abstract][Full Text] [Related]
9. BRAF mutation analysis of fine-needle aspiration biopsies of papillary thyroid carcinoma: impact on diagnosis and prognosis. Colanta A; Lin O; Tafe L; Ghossein R; Nafa K; Mitchell T; Ladanyi M; Arcila M Acta Cytol; 2011; 55(6):563-9. PubMed ID: 22156467 [TBL] [Abstract][Full Text] [Related]
11. BRAF analysis before surgery for papillary thyroid carcinoma: correlation with clinicopathological features and prognosis in a single-institution prospective experience. Galuppini F; Pennelli G; Vianello F; Censi S; Zambonin L; Watutantrige-Fernando S; Manso J; Nacamulli D; Lora O; Pelizzo MR; Rugge M; Barollo S; Mian C Clin Chem Lab Med; 2016 Sep; 54(9):1531-9. PubMed ID: 26863344 [TBL] [Abstract][Full Text] [Related]
12. BRAF analysis by fine needle aspiration biopsy of thyroid nodules improves preoperative identification of papillary thyroid carcinoma and represents a prognostic factor. A mono-institutional experience. Pelizzo MR; Boschin IM; Barollo S; Pennelli G; Toniato A; Zambonin L; Vianello F; Piotto A; Ide EC; Pagetta C; Sorgato N; Torresan F; Girelli ME; Nacamulli D; Mantero F; Mian C Clin Chem Lab Med; 2011 Feb; 49(2):325-9. PubMed ID: 21175381 [TBL] [Abstract][Full Text] [Related]
13. Utility of BRAF mutation detection in fine-needle aspiration biopsy samples read as "suspicious for papillary thyroid carcinoma". Jara SM; Bhatnagar R; Guan H; Gocke CD; Ali SZ; Tufano RP Head Neck; 2015 Dec; 37(12):1788-93. PubMed ID: 24989827 [TBL] [Abstract][Full Text] [Related]
14. Use of BRAF v600e immunocytochemistry on FNA direct smears of papillary thyroid carcinoma. Wobker SE; Kim LT; Hackman TG; Dodd LG Cancer Cytopathol; 2015 Sep; 123(9):531-9. PubMed ID: 26080065 [TBL] [Abstract][Full Text] [Related]